Monthly Archives: April 2019

Lactose Free Dairy Products Market 2019 Global Share, Supply, Demand, Segmentation and Forecast to 2025

Wiseguyreports.Com Adds “Lactose Free Dairy Products 2019-2025 Global Market Survey Industry Key Players – Valio, Shamrock, Arla, Dean, Danone” To Its Research Database

Pune, India – April 25, 2019 /MarketersMedia/

Lactose Free Dairy Products Market 2019-2025

Description: –

A major consumer shift towards organic food and beverages has been witnessed in the food and beverages market of Western Europe since the past few years. This shift has occurred mainly due to increasing awareness among consumers regarding the unethical and synthetic ingredients in non-organic food and beverages products. This is the precise reason that production of organic milk is stringently regulated in this region and even to sell milk one needs to obtain the necessary license from relevant authorities.

By product type, the yoghurt segment was valued at more than US$ 2,300 Mn in the year 2017 and by the end of the projected period, the yoghurt segment is likely to reach a market valuation of more than US$ 4,000 Mn, expanding at a CAGR of 4.7%.

Scope of the Report:

The global Lactose Free Dairy Products market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Lactose Free Dairy Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lactose Free Dairy Products market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

Free Sample Report @ https://www.wiseguyreports.com/sample-request/3851025-global-lactose-free-dairy-products-market-research-report-2019

The major manufacturers covered in this report

Valio
Shamrock
Arla
Dean
Danone
Murray Goulburn
Nestle

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Milk
Condensed Milk
Milk Powder
Yoghurt
Ice Cream
Deserts
Butter/Cheese
Infant Formula
Processed Milk Products

Segment by Application
Grocery Store
Supermarket
Others

Leave a Query @ https://www.wiseguyreports.com/enquiry/3851025-global-lactose-free-dairy-products-market-research-report-2019

Major Key Points in Table of Content:

1 Lactose Free Dairy Products Market Overview
1.1 Product Overview and Scope of Lactose Free Dairy Products
1.2 Lactose Free Dairy Products Segment by Type
1.2.1 Global Lactose Free Dairy Products Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Milk
1.2.3 Condensed Milk
1.2.4 Milk Powder
1.2.5 Yoghurt
1.2.6 Ice Cream
1.2.7 Deserts
1.2.8 Butter/Cheese
1.2.9 Infant Formula
1.2.10 Processed Milk Products
1.3 Lactose Free Dairy Products Segment by Application
1.3.1 Lactose Free Dairy Products Consumption Comparison by Application (2014-2025)
1.3.2 Grocery Store
1.3.3 Supermarket
1.3.4 Others
1.4 Global Lactose Free Dairy Products Market by Region
1.4.1 Global Lactose Free Dairy Products Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Lactose Free Dairy Products Market Size
1.5.1 Global Lactose Free Dairy Products Revenue (2014-2025)
1.5.2 Global Lactose Free Dairy Products Production (2014-2025)

…………….

7 Company Profiles and Key Figures in Lactose Free Dairy Products Business
7.1 Valio
7.1.1 Valio Lactose Free Dairy Products Production Sites and Area Served
7.1.2 Lactose Free Dairy Products Product Introduction, Application and Specification
7.1.3 Valio Lactose Free Dairy Products Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Shamrock
7.2.1 Shamrock Lactose Free Dairy Products Production Sites and Area Served
7.2.2 Lactose Free Dairy Products Product Introduction, Application and Specification
7.2.3 Shamrock Lactose Free Dairy Products Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Arla
7.3.1 Arla Lactose Free Dairy Products Production Sites and Area Served
7.3.2 Lactose Free Dairy Products Product Introduction, Application and Specification
7.3.3 Arla Lactose Free Dairy Products Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Dean
7.4.1 Dean Lactose Free Dairy Products Production Sites and Area Served
7.4.2 Lactose Free Dairy Products Product Introduction, Application and Specification
7.4.3 Dean Lactose Free Dairy Products Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Danone
7.5.1 Danone Lactose Free Dairy Products Production Sites and Area Served
7.5.2 Lactose Free Dairy Products Product Introduction, Application and Specification
7.5.3 Danone Lactose Free Dairy Products Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Murray Goulburn
7.6.1 Murray Goulburn Lactose Free Dairy Products Production Sites and Area Served
7.6.2 Lactose Free Dairy Products Product Introduction, Application and Specification
7.6.3 Murray Goulburn Lactose Free Dairy Products Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served

Continued……

For Detailed Report Visit @ https://www.wiseguyreports.com/reports/3851025-global-lactose-free-dairy-products-market-research-report-2019

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com/

Source URL: https://marketersmedia.com/lactose-free-dairy-products-market-2019-global-share-supply-demand-segmentation-and-forecast-to-2025/506720

Source: MarketersMedia

Release ID: 506720

Bubble Tea Market 2019 – Global Sales,Price,Revenue,Gross Margin and Market Share

WiseGuyReports.Com Publish a New Market Research Report On –“ Bubble Tea Market 2019 – Global Sales,Price,Revenue,Gross Margin and Market Share”.

Pune, India – April 25, 2019 /MarketersMedia/

Bubble Tea Industry 2019

Description:-

The Bubble Tea industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Bubble Tea market size to maintain the average annual growth rate of 2.58% from 630 million $ in 2015 to 680 million $ in 2018, The analysts believe that in the next few years, Bubble Tea market size will be further expanded, we expect that by 2023, The market size of the Bubble Tea will reach 720 million $.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3829777-global-bubble-tea-market-report-2019

For more information or any query mail at sales@wiseguyreports.com

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

Sections:-

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail
HYE
Bossen
Bubble Tea House Company
Bubblelicious Tea
Lollicup USA Inc.
Sumos
CuppoTee Company
Premium Bubble Tea manufacturers
Boba Tea Company
Ten Ren’s Tea
Qbubble

Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

……

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3829777-global-bubble-tea-market-report-2019

Table Of Contents – Major Key Points

Section 1 Bubble Tea Product Definition

Section 2 Global Bubble Tea Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Bubble Tea Shipments
2.2 Global Manufacturer Bubble Tea Business Revenue
2.3 Global Bubble Tea Market Overview

Section 3 Manufacturer Bubble Tea Business Introduction
3.1 HYE Bubble Tea Business Introduction
3.1.1 HYE Bubble Tea Shipments, Price, Revenue and Gross profit 2015-2018
3.1.2 HYE Bubble Tea Business Distribution by Region
3.1.3 HYE Interview Record
3.1.4 HYE Bubble Tea Business Profile
3.1.5 HYE Bubble Tea Product Specification
3.2 Bossen Bubble Tea Business Introduction
3.2.1 Bossen Bubble Tea Shipments, Price, Revenue and Gross profit 2015-2018
3.2.2 Bossen Bubble Tea Business Distribution by Region
3.2.3 Interview Record
3.2.4 Bossen Bubble Tea Business Overview
3.2.5 Bossen Bubble Tea Product Specification
3.3 Bubble Tea House Company Bubble Tea Business Introduction
3.3.1 Bubble Tea House Company Bubble Tea Shipments, Price, Revenue and Gross profit 2015-2018
3.3.2 Bubble Tea House Company Bubble Tea Business Distribution by Region
3.3.3 Interview Record
3.3.4 Bubble Tea House Company Bubble Tea Business Overview
3.3.5 Bubble Tea House Company Bubble Tea Product Specification
3.4 Bubblelicious Tea Bubble Tea Business Introduction
3.5 Lollicup USA Inc. Bubble Tea Business Introduction
3.6 Sumos Bubble Tea Business Introduction

Section 4 Global Bubble Tea Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Bubble Tea Market Size and Price Analysis 2015-2018
4.1.2 Canada Bubble Tea Market Size and Price Analysis 2015-2018
4.2 South America Country
4.2.1 South America Bubble Tea Market Size and Price Analysis 2015-2018
4.3 Asia Country
4.3.1 China Bubble Tea Market Size and Price Analysis 2015-2018
4.3.2 Japan Bubble Tea Market Size and Price Analysis 2015-2018
4.3.3 India Bubble Tea Market Size and Price Analysis 2015-2018
4.3.4 Korea Bubble Tea Market Size and Price Analysis 2015-2018
4.4 Europe Country
4.4.1 Germany Bubble Tea Market Size and Price Analysis 2015-2018
4.4.2 UK Bubble Tea Market Size and Price Analysis 2015-2018
4.4.3 France Bubble Tea Market Size and Price Analysis 2015-2018
4.4.4 Italy Bubble Tea Market Size and Price Analysis 2015-2018
4.4.5 Europe Bubble Tea Market Size and Price Analysis 2015-2018
4.5 Other Country and Region
4.5.1 Middle East Bubble Tea Market Size and Price Analysis 2015-2018
4.5.2 Africa Bubble Tea Market Size and Price Analysis 2015-2018
4.5.3 GCC Bubble Tea Market Size and Price Analysis 2015-2018
4.6 Global Bubble Tea Market Segmentation (Region Level) Analysis 2015-2018
4.7 Global Bubble Tea Market Segmentation (Region Level) Analysis

Section 5 Global Bubble Tea Market Segmentation (Product Type Level)
5.1 Global Bubble Tea Market Segmentation (Product Type Level) Market Size 2015-2018
5.2 Different Bubble Tea Product Type Price 2015-2018
5.3 Global Bubble Tea Market Segmentation (Product Type Level) Analysis

Section 6 Global Bubble Tea Market Segmentation (Industry Level)
6.1 Global Bubble Tea Market Segmentation (Industry Level) Market Size 2015-2018
6.2 Different Industry Price 2015-2018
6.3 Global Bubble Tea Market Segmentation (Industry Level) Analysis

Section 7 Global Bubble Tea Market Segmentation (Channel Level)
7.1 Global Bubble Tea Market Segmentation (Channel Level) Sales Volume and Share 2015-2018
7.2 Global Bubble Tea Market Segmentation (Channel Level) Analysis

Continued……

Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3829777

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/bubble-tea-market-2019-global-salespricerevenuegross-margin-and-market-share/506722

Source: MarketersMedia

Release ID: 506722

Global Soap Noodles Market Research Report, Market size, Status, Revenue, Consumption, Import and Future Forecast to 2019-2024

Wiseguyreports.Com Adds “Soap Noodles – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2024” To Its Research Database

Pune, India – April 25, 2019 /MarketersMedia/

Global Soap Noodles Market Report 2019 – Market Size, Share, Price, Trend and Forecast

Wiseguyreports.Com Adds “Soap Noodles – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2024” To Its Research Database

The global market size of Soap Noodles is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.

Global Soap Noodles Market Report 2019 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Soap Noodles industry. The key insights of the report:

1.The report provides key statistics on the market status of the Soap Noodles manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report estimates 2019-2024 market development trends of Soap Noodles industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report makes some important proposals for a new project of Soap Noodles Industry before evaluating its feasibility.

 Get Free Sample Report of Soap Noodles Market@ https://www.wiseguyreports.com/sample-request/3946201-global-soap-noodles-market-report-2019-market-size-share-price-trend-and-forecast

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

For competitor segment, the report includes global key players of Soap Noodles as well as some small players. At least 10 companies are included: 
* Deeno Group
* Wilmar international
* Muslim Mas Holdings
* Kuala Lumpur Kepong (KLK OLEO)
* 3F Group
* Adimulia Sarimas Indonesia

For complete companies list, please ask for sample pages.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Soap Noodles market
* Vegetable Oil
* Tallow

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Household Use
* Industrial Use
* Special Purpose
For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions:
* North America
* South America
* Asia & Pacific
* Europe
* MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
Reasons to Purchase this Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.

Complete report with Comprehensive table of contents@ https://www.wiseguyreports.com/reports/3946201-global-soap-noodles-market-report-2019-market-size-share-price-trend-and-forecast   

Major Key Points in Table of Content

Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
    3.1 Research Scope
3.2 Research Methodology
3.2.1 Primary Sources
3.2.2 Secondary Sources
3.2.3 Assumptions

Chapter 16 Analysis of Global Key Vendors
    16.1 Michelin
16.1.1 Company Profile
16.1.2 Main Business and Snow Tire Information
16.1.3 SWOT Analysis of Michelin
16.1.4 Michelin Snow Tire Sales, Revenue, Price and Gross Margin (2014-2019)
16.2 Goodyear
16.2.1 Company Profile
16.2.2 Main Business and Snow Tire Information
16.2.3 SWOT Analysis of Goodyear
16.2.4 Goodyear Snow Tire Sales, Revenue, Price and Gross Margin (2014-2019)
16.3 Continental
16.3.1 Company Profile
16.3.2 Main Business and Snow Tire Information
16.3.3 SWOT Analysis of Continental
16.3.4 Continental Snow Tire Sales, Revenue, Price and Gross Margin (2014-2019)
16.4 Pirelli
16.4.1 Company Profile
16.4.2 Main Business and Snow Tire Information
16.4.3 SWOT Analysis of Pirelli
16.4.4 Pirelli Snow Tire Sales, Revenue, Price and Gross Margin (2014-2019)
16.5 Hankook
16.5.1 Company Profile
16.5.2 Main Business and Snow Tire Information
16.5.3 SWOT Analysis of Hankook
16.5.4 Hankook Snow Tire Sales, Revenue, Price and Gross Margin (2014-2019)
16.6 Sumitomo
16.6.1 Company Profile
16.6.2 Main Business and Snow Tire Information
16.6.3 SWOT Analysis of Sumitomo
16.6.4 Sumitomo Snow Tire Sales, Revenue, Price and Gross Margin (2014-2019)
16.7 Yokohama
16.7.1 Company Profile
16.7.2 Main Business and Snow Tire Information
16.7.3 SWOT Analysis of Yokohama
16.7.4 Yokohama Snow Tire Sales, Revenue, Price and Gross Margin (2014-2019)

 Continued…………………….

 

Buy Soap Noodles Market Report Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3946201       

 

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Website: https://www.wiseguyreports.com/sample-request/3946201-global-soap-noodles-market-report-2019-market-size-share-price-trend-and-forecast

Source URL: https://marketersmedia.com/global-soap-noodles-market-research-report-market-size-status-revenue-consumption-import-and-future-forecast-to-2019-2024/506724

Source: MarketersMedia

Release ID: 506724

Pneumonia Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2025

WiseGuyRerports.com Presents “Global Pneumonia Therapeutics Market Research Report 2019” New Document to its Studies Database

Pune, India – April 25, 2019 /MarketersMedia/

Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. 
The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years.

The global Pneumonia Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. 
This report focuses on Pneumonia Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumonia Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. 
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered: 
GlaxoSmithKline 
Merck Sharp & Dohme 
Novartis 
Pfizer 
AstraZeneca 
Bayer 
Biotest 
Tetraphase Pharmaceuticals

 

 Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3836498-global-pneumonia-therapeutics-market-research-report-2019                                    

                                     

Segment by Regions 
North America 
Europe 
China 
Japan

Segment by Type 
Vaccines 
Anti-Infectives 
Oxygen Therapy

Segment by Application 
Hospital 
Clinic 
Medical Center 
Other

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3836498-global-pneumonia-therapeutics-market-research-report-2019                             

Table Of Contents:      

1 Pneumonia Therapeutics Market Overview 
1.1 Product Overview and Scope of Pneumonia Therapeutics 
1.2 Pneumonia Therapeutics Segment by Type 
1.2.1 Global Pneumonia Therapeutics Production Growth Rate Comparison by Type (2014-2025) 
1.2.2 Vaccines 
1.2.3 Anti-Infectives 
1.2.4 Oxygen Therapy 
1.3 Pneumonia Therapeutics Segment by Application 
1.3.1 Pneumonia Therapeutics Consumption Comparison by Application (2014-2025) 
1.3.2 Hospital 
1.3.3 Clinic 
1.3.4 Medical Center 
1.3.5 Other 
1.4 Global Pneumonia Therapeutics Market by Region 
1.4.1 Global Pneumonia Therapeutics Market Size Region 
1.4.2 North America Status and Prospect (2014-2025) 
1.4.3 Europe Status and Prospect (2014-2025) 
1.4.4 China Status and Prospect (2014-2025) 
1.4.5 Japan Status and Prospect (2014-2025) 
1.5 Global Pneumonia Therapeutics Market Size 
1.5.1 Global Pneumonia Therapeutics Revenue (2014-2025) 
1.5.2 Global Pneumonia Therapeutics Production (2014-2025)

2 Global Pneumonia Therapeutics Market Competition by Manufacturers 
2.1 Global Pneumonia Therapeutics Production Market Share by Manufacturers (2014-2019) 
2.2 Global Pneumonia Therapeutics Revenue Share by Manufacturers (2014-2019) 
2.3 Global Pneumonia Therapeutics Average Price by Manufacturers (2014-2019) 
2.4 Manufacturers Pneumonia Therapeutics Production Sites, Area Served, Product Types 
2.5 Pneumonia Therapeutics Market Competitive Situation and Trends 
2.5.1 Pneumonia Therapeutics Market Concentration Rate 
2.5.2 Pneumonia Therapeutics Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

7 Company Profiles and Key Figures in Pneumonia Therapeutics Business 
7.1 GlaxoSmithKline 
7.1.1 GlaxoSmithKline Pneumonia Therapeutics Production Sites and Area Served 
7.1.2 Pneumonia Therapeutics Product Introduction, Application and Specification 
7.1.3 GlaxoSmithKline Pneumonia Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 
7.1.4 Main Business and Markets Served 
7.2 Merck Sharp & Dohme 
7.2.1 Merck Sharp & Dohme Pneumonia Therapeutics Production Sites and Area Served 
7.2.2 Pneumonia Therapeutics Product Introduction, Application and Specification 
7.2.3 Merck Sharp & Dohme Pneumonia Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 
7.2.4 Main Business and Markets Served 
7.3 Novartis 
7.3.1 Novartis Pneumonia Therapeutics Production Sites and Area Served 
7.3.2 Pneumonia Therapeutics Product Introduction, Application and Specification 
7.3.3 Novartis Pneumonia Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 
7.3.4 Main Business and Markets Served 
7.4 Pfizer 
7.4.1 Pfizer Pneumonia Therapeutics Production Sites and Area Served 
7.4.2 Pneumonia Therapeutics Product Introduction, Application and Specification 
7.4.3 Pfizer Pneumonia Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 
7.4.4 Main Business and Markets Served 
7.5 AstraZeneca 
7.5.1 AstraZeneca Pneumonia Therapeutics Production Sites and Area Served 
7.5.2 Pneumonia Therapeutics Product Introduction, Application and Specification 
7.5.3 AstraZeneca Pneumonia Therapeutics Production, Revenue, Price and Gross Margin (2014-2019) 
7.5.4 Main Business and Markets Served 

 Continued…….                                                      

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: Wiseguyreports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/pneumonia-therapeutics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2019-2025/506725

Source: MarketersMedia

Release ID: 506725

Justice Family Lawyers Award Grant To University of Technology Sydney Student

In recent interview with Eleven Media, Justice Family Lawyers confirmed that they have awarded a $3000 grant to a student currently studying at the University of Technology Sydney.

Sydney, Australia – April 25, 2019 /PressCable/

Justice Family Lawyers has provided Activate UTS with a $3000 grant to provide financial support to an athlete competing at an elite level while also undertaking studies at the University of Technology Sydney.

Further, there is an optional opportunity to participate in a 6 week internship program at Justice Family Lawyers where the sports scholar will receive legal experience and training to help compliment their legal studies.

The recipient of the award went to Michael McCrea from Rowing

Michael is a second-year student studying a Bachelor of Communication Social and Political Sciences/Bachelor of Laws.

“It’s extremely exciting to be giving back to the university that gave me so much” says Hayder Shkara, the Principal of Justice Family Lawyers.

“We are always growing and have opened a second location in Barangaroo allowing us to service Sydney’s newest precinct. Michael demonstrates all of the qualities that we strive for at Justice Family Lawyers. He is hard working and has the ability to manage his professional sporting career and his studies efficiently.”

Michael competes for the UTS Rowing Club, and was selected for the NSW Youth 8 crew in 2018 as well as the NSW team to compete at the Kings Cup at the recent 2019 National Championships. Representing UTS, he also won a gold, silver and bronze medal at this year’s nationals, and he is also a key part of the UTS team that represents at the National University Championships each year.

To learn more about Justice Family Lawyers visit their website here: https://justicefamilylawyers.com.au/

About Justice Family Lawyers

Justice Family Lawyers is Sydney based and provides expert advice on all aspects of Australian family law.

They provide legal assistance and representation on matters relating to divorce, family mediation, de facto relationships, domestic violence, separation, child custody, property settlement and going to court.

Contact Info:
Name: Mr Hayder Shkara
Organization: Justice Family Lawyers
Address: Level 2 255 Castlereagh St, Sydney, NSW 2000, Australia
Phone: +61-2-8089-3148
Website: https://justicefamilylawyers.com.au

Source: PressCable

Release ID: 506632

Sandwich Glass Market 2019 Global Trend, Segmentation And Opportunities Forecast To 2024

Wiseguyreports.Com Adds “Sandwich Glass -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

Pune, India – April 25, 2019 /MarketersMedia/

Sandwich Glass Industry

Description

The global Sandwich Glass market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Sandwich Glass by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. 

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.): 

Saint-Gobain 
Asahi Glass Co., Ltd. 
Nippon Sheet Glass Co. Ltd. 
Sisecam Group 
Taiwan Glass Ind. Corp. 
Guardian Industries 
Central Glass Co., Ltd. 
Xinyi Glass Holdings Limited 
CSG Holdings Co., Ltd. 
Fuyao Glass Industry Group Co., Ltd. 
Schott AG 
Vitro, S.A.B De C.V. 
Cardinal Glass Industries, Inc 
Press Glass SA 
Tecnoglass SA 
Shandong Yaohua Glass Co., Ltd. 
Fuso Glass India Pvt. Ltd 
AJJ Glass Ltd. 
China Specialty Glass AG 
Shanghai Yaohua Pilkington Glass Group Co., Ltd. 
China Luoyang Float Glass Group Co., Ltd. 
KCC Corporation 
Flat Glass Group Co., Ltd. 
Aeon Industries Corporation Ltd 
Scheuten Glas 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3637254-global-sandwich-glass-market-analysis-2013-2018-and-forecast-2019-2024

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): 
Polyvinyl Butyral 
Ionoplast Polymer 
Others 

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): 
Building & Construction 
Automotive 

Region Coverage (Regional Production, Demand & Forecast by Countries etc.): 
North America (U.S., Canada, Mexico) 
Europe (Germany, U.K., France, Italy, Russia, Spain etc.) 
Asia-Pacific (China, India, Japan, Southeast Asia etc.) 
South America (Brazil, Argentina etc.) 
Middle East & Africa (Saudi Arabia, South Africa etc.)

Leave a Query @ https://www.wiseguyreports.com/enquiry/3637254-global-sandwich-glass-market-analysis-2013-2018-and-forecast-2019-2024

Table of Contents

1 Industry Overview 
1.1 Sandwich Glass Industry 
1.1.1 Overview 
1.1.2 Development of Sandwich Glass 
1.2 Market Segment 
1.2.1 Upstream 
1.2.2 Downstream 
1.3 Cost Analysis 
2 Industry Environment (PEST Analysis) 
2.1 Policy 
2.2 Economics 
2.3 Sociology 
2.4 Technology 
3 Sandwich Glass Market by Type 
3.1 By Type 
3.1.1 Polyvinyl Butyral 
3.1.2 Ionoplast Polymer 
3.1.3 Others 
3.2 Market Size 
3.3 Market Forecast 
4 Major Companies List 
4.Sandwich Glass Saint-Gobain (Company Profile, Sales Data etc.) 
4.2 Asahi Glass Co., Ltd. (Company Profile, Sales Data etc.) 
4.3 Nippon Sheet Glass Co. Ltd. (Company Profile, Sales Data etc.) 
4.4 Sisecam Group (Company Profile, Sales Data etc.) 
4.5 Taiwan Glass Ind. Corp. (Company Profile, Sales Data etc.) 
4.6 Guardian Industries (Company Profile, Sales Data etc.) 
4.7 Central Glass Co., Ltd. (Company Profile, Sales Data etc.) 
4.8 Xinyi Glass Holdings Limited (Company Profile, Sales Data etc.) 
4.9 CSG Holdings Co., Ltd. (Company Profile, Sales Data etc.) 
4.10 Fuyao Glass Industry Group Co., Ltd. (Company Profile, Sales Data etc.) 
4.11 Schott AG (Company Profile, Sales Data etc.) 
4.12 Vitro, S.A.B De C.V. (Company Profile, Sales Data etc.) 
4.13 Cardinal Glass Industries, Inc (Company Profile, Sales Data etc.) 
4.14 Press Glass SA (Company Profile, Sales Data etc.) 
4.15 Tecnoglass SA (Company Profile, Sales Data etc.) 
4.16 Shandong Yaohua Glass Co., Ltd. (Company Profile, Sales Data etc.) 
4.17 Fuso Glass India Pvt. Ltd (Company Profile, Sales Data etc.) 
4.18 AJJ Glass Ltd. (Company Profile, Sales Data etc.) 
4.19 China Specialty Glass AG (Company Profile, Sales Data etc.) 
4.20 Shanghai Yaohua Pilkington Glass Group Co., Ltd. (Company Profile, Sales Data etc.) 
4.21 China Luoyang Float Glass Group Co., Ltd. (Company Profile, Sales Data etc.) 
4.22 KCC Corporation (Company Profile, Sales Data etc.) 
4.23 Flat Glass Group Co., Ltd. (Company Profile, Sales Data etc.) 
4.24 Aeon Industries Corporation Ltd (Company Profile, Sales Data etc.) 
4.25 Scheuten Glas (Company Profile, Sales Data etc.) 
5 Market Competition 
5.1 Company Competition 
5.2 Regional Market by Company 
6 Demand by End Market 
6.1 Demand Situation 
6.1.1 Demand in Building & Construction 
6.1.2 Demand in Automotive 
6.2 Regional Demand Comparison 
6.3 Demand Forecast 
7 Region Operation 
7.1 Regional Production 
7.2 Regional Market 
7.3 by Region 
7.3.1 North America 
7.3.1.1 Overview 
7.3.1.2 by Country (U.S., Canada, Mexico) 
7.3.2 Europe 
7.3.2.1 Overview 
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) 
7.3.3 Asia-Pacific 
7.3.3.1 Overview 
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) 
7.3.4 South America 
7.3.4.1 Overview 
7.3.4.2 by Country (Brazil, Argentina etc.) 
7.3.5 Middle East & Africa 
7.3.5.1 Overview 
7.3.5.2 by Country (Saudi Arabia, South Africa etc.) 
7.4 Regional Import & Export 
7.5 Regional Forecast 
8 Marketing & Price 
8.1 Price and Margin 
8.1.1 Price Trends 
8.1.2 Factors of Price Change 
8.1.3 Manufacturers Gross Margin Analysis 
8.2 Marketing Channel 
9 Research Conclusion

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3637254

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com/sample-request/3637254-global-sandwich-glass-market-analysis-2013-2018-and-forecast-2019-2024

Source URL: https://marketersmedia.com/sandwich-glass-market-2019-global-trend-segmentation-and-opportunities-forecast-to-2024/506729

Source: MarketersMedia

Release ID: 506729

TrackX Presenting at the Planet Microcap Showcase May 1, 2019

DENVER, COLORADO / ACCESSWIRE / April 25, 2019 / TrackX Holdings Inc. (TSX.V: TKX | OTC PINK: TKXHF | FRANKFURT: 3TH) (“TrackX” or the “Company), a Software-as-a-Service (SaaS)-based enterprise asset management solution provider, announced today that CEO Tim Harvie will present the Company’s investment thesis on Wednesday, May 1, 2019 at the upcoming Planet MicroCap Showcase in Las Vegas, Nevada. Mr. Harvie’s presentation begins at 1:30pm Pacific Time, and he will host one-on-one investor meetings the following day (May 2, 2019).

“I am looking forward to updating the investor community about our recent customer announcements and our growing pipeline of new enterprise accounts,” said Mr. Harvie. “Our land and expand strategy is working, as historically we have had 91% of our customers expand beyond their initial deployment. While our SaaS revenue today was at a run-rate of $2.3 million at the end of fiscal Q1 2019, the opportunity in just our existing customers represents a significant potential increase in revenue as customers deploy across their enterprise. We look forward to providing further updates to investors at the Planet MicroCap Showcase.”

About Planet MicroCap Showcase

Planet MicroCap Showcase brings together promising companies with well-known and influential microcap investors, fund managers and newsletter writers for three days of company presentations, one-on-one meetings, and networking in the nation’s #1 destination for meetings and entertainment.

The conference will be held April 30 through May 2, 2019 at Bally’s Hotel & Casino in Las Vegas – 3645 S Las Vegas Blvd., Las Vegas, NV 89109. For those interested in attending and meeting with management, you can register to attend here: https://planetmicrocapshowcase.com/signup

If you have any questions about the Planet MicroCap Showcase, please contact Robert Kraft at rkraft@snnwire.com (424) 227-9018, or visit planetmicrocapshowcase.com for more information.

About TrackX

TrackX, Inc. (TSX.V:TKX), based in Denver, Colorado, is an enterprise asset management company deploying SaaS-based solutions leveraging multiple auto-ID and sensor technologies for the comprehensive tracking and management of physical assets. TrackX’s GAME (Global Asset Management for Enterprises) platform enables the Industrial Internet of Things by providing unique item level tracking, workflow processing, event management, alerting and powerful analytics to deliver solutions across a growing number of industries. TrackX delivers significant value to a growing list of Fortune 500 companies and for customers in industries such as transportation, beverage, brewery, healthcare, hi-tech, hospitality, mining, agriculture, horticulture, manufacturing and government.

For more information, please contact:

Gene McConnell, TrackX Holdings Inc.
investor@trackx.com

303-325-7300

Sean Peasgood, Sophic Capital
Sean@SophicCapital.com

647-361-8358

Neither TSX Venture Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. All statements that address future plans, activities, events or developments that the Company believes, expects or anticipates will or may occur including the Company’s anticipated pipeline and value of current and customer deployments and future opportunities are the managements best estimates and cannot be guaranteed or relied upon and is forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements in this news release, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: TrackX Holdings Inc.

ReleaseID: 542993

Theralase Commences Phase II NMIBC Clinical Study

TORONTO, ON / ACCESSWIRE / April 25, 2019 / Theralase® Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTCQB), a clinical stage pharmaceutical company dedicated to the research and development of light-activated Photo Dynamic Compounds (“PDC”) and their associated drug formulations intended to safely and effectively destroy various cancers, announced today that the University Health Network Research Ethics Board (“UHN-REB”) has approved the commencement of a Phase II clinical study to evaluate Theralase’s Anti-Cancer Treatment (“ACT”) titled, “Patients with Non-Muscle Invasive Bladder Cancer (“NMIBC”), who present with Carcinoma In-Situ (“CIS”), who are considered Bacillus Calmette Guérin (“BCG”) – Unresponsive or are intolerant to BCG Therapy (“ACT-NMIBC”)”.

The ACT-NMIBC study has been designed in compliance with FDA industry guidelines issued February, 2018 for BCG-unresponsive NMIBC. The study will utilize the Therapeutic Dose (0.70 mg/cm) of TLD-1433 and will focus on the treatment of approximately 100 to 125 BCG-unresponsive NMIBC patients, with CIS, in approximately 20 clinical study sites in Canada, the US and internationally, with a primary endpoint of efficacy and a secondary endpoint of safety.

Study sites will be launched first in Canada, followed by the US, subject to Food and Drug Administration approval, and then internationally, subject to international regulatory approval.

The primary endpoint of the Study:

Efficacy – Evaluated by Complete Response (“CR”) in patients with CIS with or without resected papillary disease at 90 days post-treatment with a duration of CR evaluated at 360 days post-treatment.

Patient CR is defined as:

Negative cystoscopy and negative (including atypical) urine cytology

Positive cystoscopy with biopsy-proven benign or low-grade NMIBC or

Negative cystoscopy with malignant urine cytology, if cancer is found in the upper tract or prostatic urethra and random bladder biopsies are negative

The secondary endpoint of the Study is:

Safety – Evaluated by the incidence and severity of Adverse Events (“AEs”) Grade 4 or higher that do not resolve within 360 days post-treatment; whereby:

Grade 1 = Mild
Grade 2 = Moderate
Grade 3 = Severe
Grade 4 = Life-threatening or disabling
Grade 5 = Death

Shawn Shirazi, Ph.D., CEO – Drug Division, Theralase stated that, “The UHN REB approval represents a major milestone for Theralase. I am pleased that the Phase II ACT-NMIBC study has been approved and UHN is able to commence enrolling and treating patients. The safety of the ACT technology for NMIBC has been validated in the Phase Ib clinical study, demonstrating strong efficacy at 66% CR albeit in a small sample size. We look forward to demonstrating to the medical community what the ACT technology is capable of accomplishing in a larger patient population. Finding improved therapies for BCG-Unresponsive NMIBC patient population is a critical unmet medical need.”

Kipton Lade, B.Sc., M.Sc., MBA, CEO – Device Division, Theralase stated that, “The Company has focused its engineering resources on upgrading the TLC-3200 medical laser system based on clinical feedback gained in the Company’s successfully completed Phase Ib study. We are excited to introduce this next level technology into the Phase II ACT-NMIBC study.”

About Theralase® Technologies Inc.

Theralase is a clinical stage pharmaceutical company dedicated to the research and development of light-activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

Additional information is available at www.theralase.com and www.sedar.com.

This news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company’s proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as “may”, “would”, “could”, “should”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions including with respect to the ability of the Company to: adequately fund, secure the requisite regulatory approvals to commence and successfully complete a Phase II NMIBC clinical study in a timely fashion and implement its development plans. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273) x304
416.699.LASE (5273) x304
Amelia Tudo, Investor Relations Coordinator
atudo@theralase.com
www.theralase.com

SOURCE: Theralase Technologies Inc.

ReleaseID: 542911

Oncolytics Biotech(R) Announces Details of 2019 Annual General Meeting of Shareholders

CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE / April 25, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that its Annual General Meeting of Shareholders will be held on Thursday, May 2nd, 2019 at 4:00 pm ET at Vantage Venues (formerly St. Andrew’s Club & Conference Center) located at 150 King St. West, 27th Floor, Toronto, Ontario.

Following the formal business portion of the meeting, Dr. Matt Coffey, President & CEO, Kirk Look, CFO and Andrew de Guttadauro, Global Head of Business Development, will discuss the Company’s progress. Topics will include the metastatic breast cancer program, biomarker data, registration pathway, clinical plans to further leverage an inflamed phenotype, business development and anticipated milestones.

A live webcast of the presentation will begin at approximately 4:30 pm ET and be available on the company’s website at www.oncolyticsbiotech.com/investor-centre/presentations. It is recommended that listeners log on 10 minutes in advance of a live session to register and download any necessary software. An audio replay will be accessible approximately two hours following the presentation on the Oncolytics website.

About Oncolytics Biotech Inc.

Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype – turning ‘cold’ tumors ‘hot’ – through innate and adaptive immune responses to treat a variety of cancers. Pelareorep has demonstrated synergies with immune checkpoint inhibitors and may also be synergistic with other approved immuno-oncology agents. Oncolytics is currently conducting and planning additional studies in combination with checkpoint inhibitors and targeted therapies in solid and hematological malignancies, as it prepares for a phase 3 registration study in metastatic breast cancer. For further information, please visit: www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and forward-looking information under applicable Canadian securities laws (such forward-looking statements and forward-looking information are collectively referred to herein as “forward-looking statements”). Forward-looking statements, including the Company’s belief as to the potential and mode of action of REOLYSIN, also known as pelareorep, as a cancer therapeutic; and other statements related to anticipated developments in the Company’s business and technologies involve known and unknown risks and uncertainties, which could cause the Company’s actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of pelareorep as a cancer treatment, the success and timely completion of clinical studies and trials, the Company’s ability to successfully commercialize pelareorep, uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company’s quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.

Company Contact

Michael Moore
Vice President, Investor Relations & Corporate Communications
858-886-7813
mmoore@oncolytics.ca

Investor Relations

Timothy McCarthy
LifeSci Advisors
212.915.2564
tim@lifesciadvisors.com

Media Contact

Jason Spark
Canale Communications
619-849-6005
jason@canalecomm.com

SOURCE: Oncolytics Biotech Inc.

ReleaseID: 542620

Workep Launches First All-In-One Project Management Platform for G Suite

Powerful project management for cross-enterprise collaboration, customizable options, and easy access for teams anywhere

BERKELEY, CA / ACCESSWIRE / April 25, 2019 / Workep, one of the startups participating in the elite UC Berkeley Skydeck accelerator program and a Google partner company, is redefining the project management experience with the launch of the first-ever all-in-one project management platform for G Suite users. The platform allows for easy cross-enterprise collaboration, integrates seamlessly with G Suite and is extremely fast, flexible and simple to use. Workep’s single platform combines up to a dozen different business tools to provide an efficient solution for both internal and external project teams.

“The most successful work teams are filled with talented people located anywhere, collaborating with stakeholders around the world, and each brings unique skill sets, work styles, and ideas. Cross-enterprise collaboration is the strongest workforce today,” said Eduardo Alvarez, CEO, Workep. “With Workep we have created a collaboration tool that brings all of this together in one place and allows each person to customize the platform based on their needs. It is a powerful, productive yet really simple and, dare I say, fun project management tool which is completely integrated and automated with G Suite.”

Launching out of stealth, Workep has raised $1M in angel investments and has grown quickly and organically by word of mouth and online searches to more than 100,000 users. Companies like Vodafone and Norauto have adopted Workep’s platform to help with team collaboration. With a full array of views (Kanban boards, to-do lists, Gantt charts, and Agile boards) into projects, Workep will allow users to focus only on their assigned tasks. It is extremely flexible, saves employees’ time, and provides managers with an overview so they know what’s going on, who’s in charge of what, how resources are being used, as well as gain real-time awareness of any delays. Workep also integrates with Slack, GitHub, Zapier, Team Drive, and DropBox.

For interdisciplinary as well as geographically-diverse teams, Workep seamlessly centralizes the collaboration. For example, a marketing agency is overwhelmed with their day-to-day activities, with thousands of things to keep on track such as projects, tasks, client feedback, iterations, files, due dates, resources and more. Today, these workflows are spread among different tools and people lose focus and productivity breaks down. However, Workep can centralize all the information, allowing people inside the agency to collaborate, but also interact with customers and contractors without them needing an account. With a single link, customers can follow up on the project in real time, eliminating the need to create and send reports and get feedback in any other tool.

The platform’s tools and features add to Workep’s intuitive ease-of-use and set it apart from other project management solutions. The solution includes:

Fully and seamless G Suite integration (Drive, Calendar, Gmail, Hangouts, Contacts, Google Cloud)
Customizable for each individual and their work needs
Intuitive and visual Gantt Charts
Wellness time tracker
Budget Tracker
Easy to share posts, links, and files in any task on the dashboard
Ability to start conversation threads or video hangouts within the interface
Project collaboration from anywhere in the world in web and mobile app

“Some studies show that as many as 70 percent of projects fail because people use multiple tools with a variety of different types of user experiences. This leads to fragmented information and broken workflows and actually makes things more difficult, so coordinated collaboration is crucial,” continued Alvarez. “Just as G Suite brings one single user experience to everyone, Workep keeps everybody on the same page and is integrated with tools they already use so everyone can be more productive.”

Image
links available here: https://drive.google.com/drive/folders/1VuzdZa-yWNZss1WDmXUsEy2LJzZ7OK9g

About
Workep

Workep is a cross-enterprise collaboration solution fully integrated and automated to work with G Suite. Easy-to-use and powerful, Workep combines multiple tools in a single platform that can be used for both internal and external real-time collaboration. A Google partner and a participant in the elite Berkeley SkyDeck accelerator program, Workep was founded in 2016 and has employees in the USA, Colombia, Eastern Europe (Georgia) and Mexico.

To learn more about Workep or to sign up, visit https://workep.com.

Media
Contact

Erica Zeidenberg
erica@hottomato.net
925-631-0553 office
925-518-8159 mobile

SOURCE: Workep

ReleaseID: 542995